Concepedia

Susanna K. Elledge

SK

Statistics

Publications

17

Citations

982

H-Index

15

Active since

2014

Affiliations

University of California, San Francisco(Current)

Chan Zuckerberg Initiative (United States)

University of California, Berkeley

Vitalant

Stanford University

Susanna K. Elledge is an author at University of California, San Francisco specializing in life sciences, immunology, and molecular virology.

ORCID

Publications per year

2014–2024

17

Publications

17

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay

Michael J. Peluso, Saki Takahashi, Jill Hakim et al. · Science Advances · 2021 · 150 citations · Full text

, , +16

Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection

Susanna K. Elledge, Xin Zhou, James R. Byrnes et al. · Nature Biotechnology · 2021 · 142 citations · Full text

, , +16

Nanoporous Immunoprotective Device for Stem-Cell-Derived β-Cell Replacement Therapy

R. Shihman Chang, Gaetano Faleo, Holger A. Russ et al. · ACS Nano · 2017 · 91 citations · Full text

, , +17

Evaluation of Three Morphologically Distinct Virus-Like Particles as Nanocarriers for Convection-Enhanced Drug Delivery to Glioblastoma

Joel A. Finbloom, Ioana L. Aanei, Jenna M. L. Bernard et al. · Nanomaterials · 2018 · 84 citations · Full text

, , +17

Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding

James R. Byrnes, Xin Zhou, Irene Lui et al. · mSphere · 2020 · 75 citations · Full text

, , +14

1–5 of 17